Latest Equity Stake News

Page 21 of 22
Hawthorn Resources has completed a pivotal Pre-Feasibility Study for its Mt Bevan Magnetite project and strategically converted its equity stake into a royalty, positioning the company for future value capture amid evolving market dynamics.
Maxwell Dee
Maxwell Dee
30 Jan 2025
Zelira Therapeutics has secured a fourth funding tranche of US$681,000, advancing its HOPE® Autism Spectrum Disorder FDA trial process and bringing total funding to US$3.25 million. The company is progressing clinical validation and product development, including the transformation of Zenivol® into a capsule formulation.
Ada Torres
Ada Torres
30 Jan 2025
Champion Iron reported solid Q3 FY2025 results despite a two-week shipment interruption, while progressing its DRPF upgrade and forging a key partnership for the Kami Project.
Maxwell Dee
Maxwell Dee
30 Jan 2025
Tivan Limited has advanced its Speewah Fluorite Project with a $7.4 million government grant and Major Project Status, alongside a joint venture MoU with Sumitomo Corporation and promising drilling results at Sandover.
Maxwell Dee
Maxwell Dee
30 Jan 2025
Champion Iron reports solid operational progress with 3.6 million wmt production and key partnerships, despite a sharp net income decline in Q3 FY2025.
Maxwell Dee
Maxwell Dee
30 Jan 2025
Cyclone Metals has forged a strategic partnership with Vale S.A. to fund and develop its Iron Bear iron ore project in Canada, marking a major step towards mining decision. The company also completed pilot production of high-grade direct reduction pellets, underscoring the project's technical promise.
Maxwell Dee
Maxwell Dee
30 Jan 2025
Strategic Energy Resources has completed a significant 25-hole drill program at its Achilles 1 Prospect, confirming widespread polymetallic mineralisation, while a new electromagnetic survey at its Mundi Project reveals promising conductors for further exploration.
Maxwell Dee
Maxwell Dee
29 Jan 2025
Zelira Therapeutics has received a fourth funding tranche, bringing total investment to US$3.25 million to support FDA clinical trials of its HOPE® 1 cannabinoid medicine targeting irritability in autism spectrum disorder and Phelan-McDermid Syndrome.
Victor Sage
Victor Sage
28 Jan 2025
BOD Science has executed an asset sale deed transferring critical intellectual property rights to Optimus Salvus, marking a pivotal step in its Deed of Company Arrangement process.
Victor Sage
Victor Sage
24 Jan 2025
Voltaic Strategic Resources has acquired a 4.2% shareholding in Geopacific Resources, gaining strategic exposure to the Woodlark Gold Project in Papua New Guinea, a well-capitalised development with a 12-year mine life and significant exploration upside.
Maxwell Dee
Maxwell Dee
24 Jan 2025
Great Divide Mining has completed its due diligence on the Adelong Gold Project, paving the way for a strategic stake acquisition and operational control aimed at resuming gold production within a year.
Maxwell Dee
Maxwell Dee
23 Jan 2025
S2 Resources reports promising exploration advances across multiple projects, including new targets at Warraweena and West Murchison, ongoing drilling at Glenlogan, and the launch of three new Victorian gold projects. The company maintains a solid cash position to support its $1.5 million planned expenditure next quarter.
Maxwell Dee
Maxwell Dee
23 Jan 2025